Our NT-proBNP test is the only quantitative direct fingerstick #NTproBNP test available on the market today, making it perfect for community-based testing. We've partnered with @EITC to deliver heart and lung screening.
https://t.co/3CopzEFYHc
Not requiring phlebotomy by offering the only direct fingerstick NT-proBNP #POC test available, simplifies heart health checks significantly. Join us on the #starttalkingaboutyourheart bus tomorrow for a FREE heart health check. #POCT#HeartFailure
The LumiraDx CRP Test can aid in the assessment of infection, tissue injury, and inflammatory conditions and guide treatment decisions including the requirement for antibiotics in respiratory infection. https://t.co/dFFe78YpGy
#POCT#CRP#LMDX
Based on a detailed analysis of the specific mutations in the #Omicron variant, @LumiraDx is confident that the performance of our #antigen and #molecular tests will not be impacted by these mutations. #LMDX#diagnostics#COVID19
https://t.co/w0eVb1bHYM
LumiraDx Quantitative POC #Ddimer test shows equivalency with well-established laboratory methodology. Accurately measured D-Dimer and was easy to use @cardio_Therapy. https://t.co/87WY1idS0d
#LMDX#diagnostics
Today we announced we have received emergency use approval from India’s Central Drugs Standard Control Organisation for our SARS-CoV-2 Antigen test for use in India.
#covid19testing $LMDX #india#sarscov2#POCT
https://t.co/zYJCuCeHpc
We are delighted to announce that #LumiraDx will be listed to trade today on @Nasdaq under the ticker symbol LMDX. Join us for the opening bell live from Times Square, streaming begins at 9am, ceremony at 9.20am ET: https://t.co/omXPx87PXy
#NasdaqListed#LMDX
#LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp. https://t.co/cK204H48Gk
#nasdaqlisted#lmdx
LumiraDx are pleased to be participating in RCGP: A Fresh Approach to General Practice. Look out for our poster, P:1221 – Establishing an Anticoagulation “Drive Through” Clinic during the COVID-19 Pandemic using the LumiraDx Platform INR Test. https://t.co/LMbCBs789G
#RCGPFA
We are proud to announce a Global Partnership to Introduce the LumiraDx Point-of-Care Diagnostic Platform for COVID-19 Antigen Testing in Africa
#covid19#antigen#lumiradx
https://t.co/C5zSGytNUR